Results 151 to 160 of about 10,491 (187)
Antiretroviral medications for pediatric use in the context of the Unified Health System: are there therapeutic gaps in Brazil? [PDF]
Rev Paul PediatrCosta SMD, Aguiar PM.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 2008
* Raltegravir, the first in a new class of orally administered HIV type-1 (HIV-1) integrase inhibitors, selectively inhibits the strand transfer activity of HIV-1 and its integration into human DNA, a key stage in retroviral propagation, thereby limiting viral replication and the infection of new cells.
Jamie D, Croxtall +2 more
+6 more sources
* Raltegravir, the first in a new class of orally administered HIV type-1 (HIV-1) integrase inhibitors, selectively inhibits the strand transfer activity of HIV-1 and its integration into human DNA, a key stage in retroviral propagation, thereby limiting viral replication and the infection of new cells.
Jamie D, Croxtall +2 more
+6 more sources
The Effect of Raltegravir on the Glucuronidation of Lamotrigine
Journal of Clinical Pharmacology, 2009 Contains fulltext : 81310.pdf (Publisher’s version ) (Closed access)The authors studied the effect of raltegravir on the pharmacokinetics of the antiepileptic agent lamotrigine.
Matthijs Van Luin, Angela Colbers
exaly +2 more sources